Dispersal of Group A Streptococcal Biofilms by the Cysteine Protease SpeB Leads to Increased Disease Severity in a Murine Model
2011

Dispersal of Group A Streptococcal Biofilms Leads to Increased Disease Severity

Sample size: 10 publication 10 minutes Evidence: high

Author Information

Author(s): Kristie L. Connolly, Amity L. Roberts, Robert C. Holder, Sean D. Reid

Primary Institution: Wake Forest University School of Medicine

Hypothesis

Does the dispersal of Group A Streptococcal biofilms by the cysteine protease SpeB lead to increased disease severity in a murine model?

Conclusion

The study found that the loss of biofilm formation in a specific strain of Group A Streptococcus resulted in increased virulence and larger lesions in infected mice.

Supporting Evidence

  • MGAS5005Δsrv infected animals developed significantly larger lesions than wild-type infected animals.
  • Treatment with a chemical inhibitor of SpeB significantly reduced lesion formation.
  • Histopathology showed greater necrosis in MGAS5005Δsrv infected samples.

Takeaway

When a certain bacteria changes how it grows, it can make people sicker. In this study, a bacteria that usually forms protective clusters was found to cause bigger infections when it couldn't form those clusters.

Methodology

Mice were infected with either the wild-type or mutant strains of Group A Streptococcus, and lesion sizes and weight loss were measured over time.

Limitations

The study was conducted in a murine model, which may not fully replicate human disease.

Participant Demographics

Five-week-old, outbred, immunocompetent, hairless female mice were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0018984

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication